Transformation in Trials

Every week we give our guests a Magic Wand that can change one thing in the Life Sciences industry. This week, Jill Pellegrino wishes that we include the 90% of patients in trials, that currently do not get the opportunity. We hope this wish is granted! Listen or watch the episode on your preferred platform 👇 🎧 On Apple Podcasts, Spotify or any other player 📽 YouTube https://lnkd.in/eVtFhdqQ 🌐 on our website: https://lnkd.in/eAq5F9ix

This week Ivanna Rosendal speaks to Jill Pellegrino, the CEO of AutoCruitment. This episode reveals alarming statistics about patient access to clinical trials, highlighting that only 😬 3% of patients currently have access to participate. Jill shares innovative strategies to ✋ engage the other 90% of the patient population and discusses the importance of digital advertising, pre-screening, and patient support in the recruitment process. • Discussion on the low percentage of patient access to clinical trials  • Barriers for physicians and research sites in patient enrollment  • Strategies to engage patients through digital advertising  • Importance of pre-screening for trial eligibility  • The role of EMR technology in improving recruitment  • Ensuring patient engagement post-initial interest  • Feedback and response from clinical trial sites  • Future plans for wider patient access to clinical trials  • Emphasis on patient-centric approaches in clinical research #clinicaltrialrecruitment #cro #clinicaltrials #lifesciences

Some time ago we had Federico Renzo Grayeb on the show to talk about pharma executives and their job embeddedness. He has since finalized his research and shared it with us! Find out what the dynamics are for pharma executives: https://lnkd.in/ea3_edXk

What are the ✨ 7 most talked about factors with the potential to transform clinical trials? Read my article for Clinical Leader to find out! It is great when a project that I have been putting a lot of 👨🌾 effort into, starts giving back. The article below is based on the more than 🎧 80 interviews conducted on the show - and it aggregates the individual opinions to become actual data points. The vision of discovering what in fact can transform clinical trials is coming closer to grasp. #clinicaltrials #transformation #lifesciences https://lnkd.in/eXheBGxs

How do you ↗️scale from a two person 🤠cowboy operation, to a sustainable endevoir? You delegate. You automate. You standardize. But first of all - you 😔admit to yourself that you cannot do it all alone. I have now admitted that. Besides delivering excellent content to our listeners, Transformation in Trials should be a 🤩great experience for our guests. To ensure that the guest experience remains great - I am now 👀looking for a part time assistant. It is very much part time. So probably falls into the category of virtual assistant. If you happen to know anyone though - let me know! #virtualassistant #hiring

Every week on the show, Ivanna Rosendal asks our guests what they would change in our industry, if they got the Transformation in Trials Magic Wand. This week, Sunil Gupta wishes for more knowledge sharing about using R for clinical trials. We wholeheartedly endorse this wish! #magicwand #opensource #r Listen or watch the episode on your preferred platform 👇 🎧 On Apple Podcasts, Spotify or any other player 📽 YouTube https://lnkd.in/eVtFhdqQ 🌐 on our website: https://lnkd.in/eAq5F9ix

This week on the show Ivanna Rosendal speaks to Sunil Gupta about why SAS has been the cornerstone of clinical trials for decades, and what is causing the shift to R now? Sunil elaborates on SAS's long-standing dominance due to its robust programming capabilities and ease of use for FDA reviewers. However, the landscape is changing as R garners attention for its graphical prowess and collaborative potential. Our discussion takes a deep dive into the collaborative spirit driving this transition, particularly through initiatives like Pharmaverse. This specialized extension is designed to optimize clinical data workflows within the pharmaceutical industry. Sunil shares insights into how clinical programming is evolving, focusing on standardized data models and the unification of CDISC standards. The conversation underscores the importance of collaboration and resource sharing, allowing organizations to tackle complex challenges efficiently and improve patient outcomes while adapting to R's open-source environment and its growing acceptance in pharmaceutical submissions. Transitioning from SAS to R is not just about adopting a new tool; it's about mastering new skills and embracing change. Sunil discusses the challenges he faced when learning R, from understanding its functional approach to navigating intricate syntax. He offers personal anecdotes that reflect his journey and the broader industry shift, emphasizing the importance of validation processes and resource optimization. Listen or watch the episode on your preferred platform 👇 🎧 On Apple Podcasts, Spotify or any other player 📽 YouTube https://lnkd.in/eVtFhdqQ 🌐 on our website: https://lnkd.in/eAq5F9ix #opensource #pharmaverse #clinicalprogramming #clinicaltrials

Episode sneak peak! Next week we speak to Sunil Gupta about how R is making it's way into clinical trials, helped by new graduates who learn the language at university. Listen or watch the episode on Wednesday on your preferred platform 👇 🎧 On Apple Podcasts, Spotify or any other player 📽 YouTube https://lnkd.in/eVtFhdqQ 🌐 on our website: https://lnkd.in/eAq5F9ix

Every week on our show, we give a Magic Wand to our guest. This magic wand can change one thing in the Life Sciences industry. This week Jessica Cordes uses her wish to improve the human element in clinical trials. We completely endorse this wish! And it is repeated by many of our guests. Listen or watch the episode on your preferred platform 👇 🎧 On Apple Podcasts, Spotify or any other player 📽 YouTube https://lnkd.in/eVtFhdqQ 🌐 on our website: https://lnkd.in/eAq5F9ix #magicwand #collaboration #communication

This week, Sam Parnell speaks to Jessica Cordes about a key topic in clinical trials: How to ensure clinical vendor oversight. In this brief video, Jessica shares 🥇 gold. A great list of metrics and considerations to build into your vendor agreements. The conversation itself is even better! Listen or watch the episode on your preferred platform 👇 🎧 On Apple Podcasts, Spotify or any other player 📽 YouTube https://lnkd.in/eVtFhdqQ 🌐 on our website: https://lnkd.in/eAq5F9ix #vendoroversight #clinicalresearchorganization #metrics #vendormanagement